High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer

High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer

Objective: While immunotherapy holds great potential for triple-negative breast cancer (TNBC), the lack of non-invasive biomarkers to identify beneficiaries limits the application. Methods: Paired baseline, on-treatment, and post-treatment plasma samples were collected from 195 TNBC patients receivi...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuling Xiao, Hang Zhang, Yi Xiao, Ying Wang, Jing Zhang, Qi Hua, Pengchen Hu, Xinyan Lyu, Weihua Shou, Xin Hu, Zhiming Shao, Yizhou Jiang, Wei Huang, Jinxiu Shi
Format: Article
Language:English
Published: China Anti-Cancer Association 2025-07-01
Series:Cancer Biology & Medicine
Subjects:
triple-negative breast cancer
immunotherapy
non-invasive biomarkers
efficacy prediction
plasma proteomic profiling
Online Access:https://www.cancerbiomed.org/content/22/7/854
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.cancerbiomed.org/content/22/7/854

Similar Items